Hydrolysis potential of recombinant human skin and kidney prolidase against diisopropylfluorophosphate and sarin by in vitro analysis

Toxicology in Vitro

Volumn 26, Issue 1, 2012, Pages 182-188

  Costante, Michael ^a   Biggemann, Lionel ^a   Alamneh, Yonas ^a   Soojhawon, Iswarduth ^a   Short, Radley ^a   Nigam, Savita ^a   Garcia, Gregory ^a   Doctor, Bhupendra P ^a   Valiyaveettil, Manojkumar ^a   Nambiar, Madhusoodana P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Catalytic bioscavenger; Chemical threat; Nerve agents; Organophosphates; Prolidase; Recombinant protein

Indexed keywords

ACETYLCHOLINESTERASE; DYFLOS; PROLINE DIPEPTIDASE; SARIN; SOMAN; TABUN;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY; LARVA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN PURIFICATION; SKIN; TRICHOPLUSIA NI;

ACETYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DIPEPTIDASES; HUMANS; HYDROLYSIS; ISOFLUROPHATE; KIDNEY; LIVER; ORGANOTHIOPHOSPHORUS COMPOUNDS; PHOSPHORIC ACID ESTERS; RECOMBINANT PROTEINS; SARIN; SKIN;

BACTERIA (MICROORGANISMS); TRICHOPLUSIA NI;

EID: 84855352357     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.11.006     Document Type: Article

References (35)

1. Besio R., Alleva S., Forlino A., Lupi A., Meneghini C., Minicozzi V., Profumo A., Stellato F., Tenni R., Morante S. Identifying the structure of the active sites of human recombinant prolidase. Eur. Biophys. J. 2010, 39:935-945.
2. Cheng T.C., Harvey S.P., Stroup A.N. Purification and properties of a highly active organophosphorus acid anhydrolase from Alteromonas undina. Appl. Environ. Microbiol. 1993, 59:3138-3140.
3. Cheng T.C., Harvey S.P., Chen G.L. Cloning and expression of a gene encoding a bacterial enzyme for decontamination of organophosphorus nerve agents and nucleotide sequence of the enzyme. Appl. Environ. Microbiol. 1996, 62:1636-1641.
4. Cheng T., Liu L., Wang B., Wu J., DeFrank J.J., Anderson D.M., Rastogi V.K., Hamilton A.B. Nucleotide sequence of a gene encoding an organophosphorus nerve agent degrading enzyme from Alteromonas haloplanktis. J. Ind. Microbiol. Biotechnol. 1997, 18:49-55.
5. Cheng T.C., Rastogi V.K., DeFrank J.J., Sawiris G.P. G-type nerve agent decontamination by Alteromonas prolidase. Ann. N. Y. Acad. Sci. 1998, 864:253-258.
6. Cheng T.C., DeFrank J.J., Rastogi V.K. Alteromonas prolidase for organophosphorus G-agent decontamination. Chem. Biol. Interact. 1999, 119-120:455-462.
7. Christensen J.E., Dudley E.G., Pederson J.A., Steele J.L. Peptidases and amino acid catabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 1999, 76:217-246.
8. Colonna C., Conti B., Perugini P., Pavanetto F., Modena T., Dorati R., Genta I. Chitosan glutamate nanoparticles for protein delivery: development and effect on prolidase stability. J. Microencapsul. 2007, 24:553-564.
9. Colonna C., Conti B., Perugini P., Pavanetto F., Modena T., Dorati R., Iadarola P., Genta I. Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy. Eur. J. Pharm. Biopharm. 2008, 70:58-65.
10. diTargiani R.C., Chandrasekaran L., Belinskaya T., Saxena A. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity. Chem. Biol. Interact. 2010, 187:349-354.
11. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
12. Endo F., Motohara K., Indo Y., Matsuda I. Immunochemical studies of human prolidase with monoclonal and polyclonal antibodies: absence of the subunit of prolidase in erythrocytes from a patient with prolidase deficiency. Pediatr. Res. 1987, 22:627-633.
13. Endo F., Tanoue A., Hata A., Kitano A., Matsuda I. Deduced amino acid sequence of human prolidase and molecular analyses of prolidase deficiency. J. Inherit. Metab Dis. 1989, 12:351-354.
14. Endo F., Tanoue A., Nakai H., Hata A., Indo Y., Titani K., Matsuda I. Primary structure and gene localization of human prolidase. J. Biol. Chem. 1989, 264:4476-4481.
15. Ishii T., Tsujino S., Matsunobu S., Endo F., Sato K., Sakuragawa N. Cloning of mouse prolidase cDNA: predominant expression of prolidase mRNA in kidney. Biochim. Biophys. Acta 1996, 1308:15-16.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
17. Lewis W.H., Harris H. Peptidase D (prolidase) variants in man. Ann. Hum. Genet. 1969, 32:317-322.
18. Lupi A., Rossi A., Vaghi P., Gallanti A., Cetta G., Forlino A. N-Benzyloxycarbonyl-l-proline: an in vitro and in vivo inhibitor of prolidase. Biochim. Biophys. Acta 2005, 1744:157-163.
19. Lupi A., Tenni R., Rossi A., Cetta G., Forlino A. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino. Acids 2008, 35:739-752.
20. Nakayama K., Awata S., Zhang J., Kaba H., Manabe M., Kodama H. Characteristics of prolidase from the erythrocytes of normal humans and patients with prolidase deficiency and their mother. Clin. Chem. Lab Med. 2003, 41:1323-1328.
21. Otto T.C., Kasten S.A., Kovaleva E., Liu Z., Buchman G., Tolosa M., Davis D., Smith J.R., Balcerzak R., Lenz D.E., Cerasoli D.M. Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae. Chem. Biol. Interact. 2010, 187:388-392.
22. Park M.S., Hill C.M., Li Y., Hardy R.K., Khanna H., Khang Y.H., Raushel F.M. Catalytic properties of the PepQ prolidase from Escherichia coli. Arch. Biochem. Biophys. 2004, 429:224-230.
23. Perugini P., Hassan K., Genta I., Modena T., Pavanetto F., Cetta G., Zanone C., Iadarola P., Asti A., Conti B. Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients. J. Control Release 2005, 102:181-190.
24. Piuri M., Sanchez-Rivas C., Ruzal S.M. Adaptation to high salt in Lactobacillus: role of peptides and proteolytic enzymes. J. Appl. Microbiol. 2003, 95:372-379.
25. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Generation and initial analysis of more than 15, 000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 2002, 99:16899-16903.
26. Tanoue A., Endo F., Akaboshi I., Oono T., Arata J., Matsuda I. Molecular defect in siblings with prolidase deficiency and absence or presence of clinical symptoms. A 0.8-kb deletion with breakpoints at the short, direct repeat in the PEPD gene and synthesis of abnormal messenger RNA and inactive polypeptide. J. Clin. Invest 1991, 87:1171-1176.
27. Theriot C.M., Tove S.R., Grunden A.M. Biotechnological applications of recombinant microbial prolidases. Adv. Appl. Microbiol. 2009, 68:99-132.
28. Theriot C.M., Du X., Tove S.R., Grunden A.M. Improving the catalytic activity of hyperthermophilic Pyrococcus prolidases for detoxification of organophosphorus nerve agents over a broad range of temperatures. Appl. Microbiol. Biotechnol. 2010, 87:1715-1726.
29. Valiyaveettil M., Alamneh Y., Biggemann L., Soojhawon I., Doctor B.P., Nambiar M.P. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1. Biochem. Biophys. Res. Commun. 2010, 403:97-102.
30. Valiyaveettil M., Alamneh Y., Biggemann L., Soojhawon I., Farag H.A., Agrawal P., Doctor B.P., Nambiar M.P. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates. Toxicol. In Vitro 2011, 25:905-913.
31. Vyas N.K., Nickitenko A., Rastogi V.K., Shah S.S., Quiocho F.A. Structural insights into the dual activities of the nerve agent degrading organophosphate anhydrolase/prolidase. Biochemistry 2010, 49:547-559.
32. Wang S.H., Liu M., Chi M.G., Wang Q.D., Sun M.J. Production of human liver prolidase by Saccharomyces cerevisiae as host cells. Acta Pharmacol. Sin. 2004, 25:794-800.
33. Wang S.H., Zhi Q.W., Sun M.J. Purification and characterization of recombinant human liver prolidase expressed in Saccharomyces cerevisiae. Arch. Toxicol. 2005, 79:253-259.
34. Wang S.H., Zhi Q.W., Sun M.J. Dual activities of human prolidase. Toxicol. In Vitro 2006, 20:71-77.
35. Wille T., Thiermann H., Worek F. Development of a high-throughput screening for nerve agent detoxifying materials using a fully-automated robot-assisted biological assay. Toxicol. In Vitro 2010, 24:1026-1031.